Description: Novacyt SA is a France-based company that develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The Company develops a secure automated cytology named NovaPrep Processor System. Novacyt SA offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The Company creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle. Novacyt SA is present in France and internationally through a network of over 10 distributors. The Company’s subsidiaries include Lab21 Ltd and Primer Design Ltd both based in the United Kingdom.
Home Page: www.novacyt.com
NCYT Technical Analysis
13 Avenue Morane Saulnier
Vélizy-Villacoublay,
78140
France
Phone:
33 1 39 46 51 04
Officers
| Name | Title |
|---|---|
| Mr. James Martin McCarthy | CFO, Acting CEO, Company Sec. & Director |
| Bryan Close | Chief Operations Officer |
| Ms. Wendy Karban | Group HR Mang. |
| Mr. David Franks | Chief HR Officer |
| Paul Oladimeji | Group Head of R&D |
| Mr. Gérald Ulrich | Chief Exec. Officer of Bus. Devel. |
| Mr. Steve Gibson | Group Financial Controller |
Exchange: LSE
Country: UK
Currency: Pence sterling (p)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4244 |
| Price-to-Sales TTM: | 0.792 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 210 |